Janssen ADC License Agreement with LegoChem Biosciences, Inc.
Sexton Riley LLP represented Janssen Biotech, Inc. in a license agreement with LegoChem Biosciences, Inc. for LCB84, a clinical stage...
top of page
SRH LLP
News & Articles
Search
- Jul 10, 2023
Janssen License Agreement with Nanobiotix
Sexton Riley LLP represented Janssen Pharmaceutica NV in a license agreement with Nanobiotix for a clinical stage radioenhancer for use...
- May 2, 2023
Janssen CAR-T Collaboration with Cellular Biomedicine Group Inc.
Sexton Riley LLP represented Janssen Biotech, Inc. in a worldwide collaboration and license agreement with Cellular Biomedicine Group...
- Apr 17, 2023
Janssen License Agreement with Pipeline Therapeutics
Sexton Riley LLP represented Janssen Pharmaceutica NV in a license and development agreement with Pipeline Therapeutics for an...
- Jun 6, 2022
Janssen CAR Design Research Agreement with Serotiny
Sexton Riley LLP represented Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in its June 2022...
- Jun 1, 2022
Hangzhou DAC - Janssen ADC Collaboration
Sexton Riley LLP represented Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in its June 2022...
- Feb 3, 2022
Janssen - Mersana ADC Collaboration
Sexton Riley LLP represented Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in its...
- Oct 4, 2021
Second Xencor - Janssen Bispecific Antibody Collaboration
Sexton Riley LLP represented Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in its October 2021...
- Oct 1, 2021
Julienne Hearn Joins Sexton Riley LLP
Sexton Riley LLP is proud to announce that Julienne Hearn has joined the firm as a partner, as of October 1, 2021. Julienne is a...
- Dec 7, 2020
Xencor - Janssen CD28 Bispecific Antibody Collaboration
Sexton Riley LLP represented Janssen Biotech, Inc., a Johnson & Johnson company, in its December 2020 research collaboration agreement...
- May 1, 2020
Janssen - Fate Therapeutics iPSC CAR NK and CAR-T Collaboration
Sexton Riley LLP Represents Janssen in Worldwide Collaboration Agreement with Fate Therapeutics for Novel iPSC-derived Cell-based Cancer...
- Dec 29, 2018
Janssen - argenx Cusatuzumab Collaboration
Sexton Riley LLP Represents Janssen Affiliate Cilag GmbH International in Worldwide Collaboration and License Agreement with argenx for...
- Dec 30, 2017
Janssen - Legend Biotech CAR-T Collaboration
Sexton Riley LLP Represents Janssen in Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop...
- May 30, 2017
Janssen-Protagonist IL-23R Collaboration
Sexton Riley LLP Represents Janssen in Worldwide Exclusive License and Collaboration Agreement with Protagonist Therapeutics May 2017...
© 2024 by Sexton Riley Hearn LLP. All rights reserved. Attorney advertising.
bottom of page